1| SENATE FLOOR VERSION | | April 21, 2025 | 2| | | | 3|ENGROSSED HOUSE | |BILL NO. 2012 By: Pae, Waldron, May, and | 4| McCane of the House | | | 5| and | | | 6| Gollihare of the Senate | | | 7| | | | 8| | | | 9| An Act relating to public health and safety; amending | | 63 O.S. 2021, Section 2-1101, which relates to | 10| harm-reduction services; deleting sunset date; and | | providing an effective date. | 11| | | | 12| | | | 13|BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | | | 14| SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-1101, is | | | 15|amended to read as follows: | | | 16| Section 2-1101. A. Until July 1,20262027, the following are | | | 17|hereby authorized to engage in harm-reduction services: | | | 18| 1. Government entities including, but not limited to, the State | | | 19|Department of Health and the Department of Mental Health and | | | 20|Substance Abuse Services; provided, no state dollars shall be used | | | 21|to purchase hypodermic needles; | | | 22| 2. Religious institutions or churches; | | | 23| 3. Nonprofit organizations; | | | 24| 4. For-profit companies; | | | arsid8323511 SENATE FLOOR VERSION - HB2012 SFLR Page 1 ___________________________________________________________________________
1| 5. Nongovernment entities partnering with a governmental | | | 2|agency; and | | | 3| 6. Tribal governments. | | | 4| B. Those offering harm-reduction services shall register with | | | 5|the State Department of Health and may engage in the following | | | 6|activities in order to reduce the use of drugs, prevent outbreaks of | | | 7|infectious diseases and reduce morbidity among people who use | | | 8|injection drugs: | | | 9| 1. Offer referrals and resources to treat substance use | | | 10|disorders; | | | 11| 2. Provide education on the risk of transmission of infectious | | | 12|diseases, including human immunodeficiency virus (HIV) and viral | | | 13|hepatitis; | | | 14| 3. Rapid testing for HIV, hepatitis C and sexually transmitted | | | 15|infections (STIs); | | | 16| 4. Referrals for medical and mental health services; | | | 17| 5. Collect used hypodermic needles for safe disposal; | | | 18| 6. Possess and distribute hypodermic needles, cleaning kits, | | | 19|test kits and opioid antagonists; and | | | 20| 7. Rapid substance testing products used, intended for use, or | | | 21|fashioned specifically for the use in identifying or analyzing the | | | 22|potency or toxicity of unknown substances. | | | 23| C. Registered providers of harm-reduction services shall report | | | 24|at least quarterly to the State Department of Health and annually to | | | arsid8323511 SENATE FLOOR VERSION - HB2012 SFLR Page 2 ___________________________________________________________________________
1|the Governor, the Speaker of the House of Representatives, and the | | | 2|President Pro Tempore of the Senate: | | | 3| 1. The number of clients served including basic demographic | | | 4|information; | | | 5| 2. Number and type of referrals provided; | | | 6| 3. Number of syringes, test kits and antagonists distributed; | | | 7| 4. Number of used syringes collected; and | | | 8| 5. Number of rapid HIV and viral hepatitis tests performed | | | 9|including the number of reactive test results. | | | 10| D. The State Commissioner of Health shall promulgate rules for | | | 11|the implementation of this section. | | | 12| SECTION 2. This act shall become effective November 1, 2025. | | | 13|COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES | |April 21, 2025 - DO PASS | 14| | | | 15| | | | 16| | | | 17| | | | 18| | | | 19| | | | 20| | | | 21| | | | 22| | | | 23| | | | 24| | | | arsid8323511 SENATE FLOOR VERSION - HB2012 SFLR Page 3